Skip to main content

Advertisement

SpringerLink
Log in

Metabolic syndrome X: An inflammatory condition?

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Obesity, atherosclerosis, insulin resistance and hyperinsulinemia, hyperlipidemia, essential hypertension, type 2 diabetes mellitus, and coronary heart disease (CHD) are the components of metabolic syndrome X and are associated with elevated plasma levels of C-reactive protein, interleukin-6, and tumor necrosis factor-α, which are markers of inflammation. This suggests that metabolic syndrome X is a low-grade, systemic, inflammatory condition. Hence, instituting anti-inflammatory measures might be beneficial in preventing or halting the progress of metabolic syndrome X in high-risk populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Hansen BC, Jen K-L, Schwartz J: Changes in insulin responses and binding in adipocytes from monkeys with obesity progressing to diabetes. Int J Obes 1988, 12:433–443.

    PubMed  CAS  Google Scholar 

  2. Bjorntorp P: Adipose tissue distribution and function. Int J Obes 1991, 15(Suppl 2):67–81.

    PubMed  Google Scholar 

  3. Pederson O, Hjollund E, Lindskov HO: Insulin binding and action on fat cells from young healthy females and males. Am J Physiol 1982, 243:E158-E167.

    Google Scholar 

  4. Ramos EJB, Xu Y, Romanova I, et al.: Is obesity an inflammatory disease? Surgery 2003, 134:329–335.

    Article  PubMed  Google Scholar 

  5. Das UN: Sex differences in the number of adipose cells. XX vs XY 2003, 1:132–133.

    Google Scholar 

  6. Masuzaki H, Paterson J, Shinyama H, et al.: A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294:2166–2170. This is an elegant study in which it was shown that mice overexpressing 11β-HSD-1 enzyme selectively in adipose tissue develop many features of metabolic syndrome X. Therefore, local activity of 11β-HSD-1 seems to play an important role in the pathogenesis of metabolic syndrome X.

    Article  PubMed  CAS  Google Scholar 

  7. Das UN: Metabolic syndrome X is common in South Asians, but why and how? Nutrition 2002, 18:774–776. This is one of the first reports to suggest that there is a close association between 11β-HSD-1, pro-inflammatory cytokines, CRP, and metabolic syndrome X, especially in Asian Indians. It was also suggested that the origins of metabolic syndrome X might have its origins in the perinatal period.

    Article  PubMed  Google Scholar 

  8. Das UN: Is metabolic syndrome X an inflammatory condition? Exp Biol Med 2002, 227:989–997. This was one of the first reports suggesting that metabolic syndrome might be an inflammatory condition. In this article, the author integrated all the existing knowledge on the relationship between low-grade systemic inflammation and metabolic syndrome X.

    CAS  Google Scholar 

  9. Das UN: Is obesity an inflammatory condition? Nutrition 2001, 17:953–966.

    Article  PubMed  CAS  Google Scholar 

  10. Das UN: Obesity, metabolic syndrome X, and inflammation. Nutrition 2002, 18:430–432.

    Article  PubMed  CAS  Google Scholar 

  11. Albert MA, Glynn RJ, Ridker PM: Plasma concentration of Creactive protein and the calculated Framingham coronary heart disease risk score. Circulation 2003, 108:161–165.

    Article  PubMed  CAS  Google Scholar 

  12. van der Meer IM, de Maat MPM, Hak AE, et al.: C-reactive protein predicts progression of atherosclerosis measured as various sites in the arterial tree. The Rotterdam Study. Stroke 2002, 33:2750–2755.

    Article  Google Scholar 

  13. Luc G, Bard J-M, Juhan-Vague I, et al.: C-reactive protein, interleukins-6, and fibrinogen as predictors of coronary heart disease. The PRIME study. Arterioscler Thromb Vasc Biol 2003, 23:1255–1261.

    Article  PubMed  CAS  Google Scholar 

  14. Ridker PM, Cushman M, Stampfer MJ, et al.: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973–979.

    Article  PubMed  CAS  Google Scholar 

  15. Engstrom G, Hedblad B, Stavenow L, et al.: Inflammationsensitive plasma proteins are associated with future weight gain. Diabetes 2003, 52:2097–2101. This article, and Mosca [16•], clearly showed the relationship between inflammation and obesity, CHD, and atherosclerosis.

    Article  PubMed  Google Scholar 

  16. Mosca L: C-reactive protein-to screen or not to screen. N Engl J Med 2002, 347:1615–1617. This article, and Engstrom et al. [15•], clearly showed the relationship between inflammation and obesity, CHD, and atherosclerosis.

    Article  PubMed  Google Scholar 

  17. Castell JV, Gomez-Lechon MJ, David M, et al.: Recombinant human interleukins-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988, 232:347–350.

    Article  PubMed  CAS  Google Scholar 

  18. Barzilay JI, Abraham L, Heckbert SR, et al.: The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes 2001, 50:2384–2389.

    Article  PubMed  CAS  Google Scholar 

  19. Kirwan JP, Krishnan RK, Weaver JA, et al.: Human aging is associated with altered TNF-alpha production during hyperglycemia and hyperinsulinemia. Am J Physiol 2001, 281:E1137-E1143.

    CAS  Google Scholar 

  20. Lin Y, Rajala MW, Berger JP, et al.: Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem 2001, 276:42077–42083. In this study, the authors clearly demonstrated that hyperglycemia induces the production of acute phase reactants including CRP, TNF-α, and IL-6.

    Article  PubMed  CAS  Google Scholar 

  21. Hotamisligil GS: The role of TNF-alpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999, 245:621–625.

    Article  PubMed  CAS  Google Scholar 

  22. Esposito K, Nappo F, Marfella R, et al.: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067–2072.

    Article  PubMed  CAS  Google Scholar 

  23. Liu S, Manson JE, Buring JE, et al.: Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002, 75:492–498.

    PubMed  CAS  Google Scholar 

  24. Mohanty P, Hamouda W, Garg R, et al.: Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000, 85:2970–2973.

    Article  PubMed  CAS  Google Scholar 

  25. Mohanty P, Ghanim H, Hamouda W, et al.: Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 2002, 75:767–772.

    PubMed  CAS  Google Scholar 

  26. Fan J, Frey RS, Rahman A, Malik AB: Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor alpha-induced NF-kB activation and intercellular adhesion molecule-1 expression in endothelial cells. J Biol Chem 2002, 277:3404–3411.

    Article  PubMed  CAS  Google Scholar 

  27. Mohan IK, Das UN: Oxidant stress, anti-oxidants and nitric oxide in non-insulin dependent diabetes mellitus. Med Sci Res 1997, 25:55–57.

    CAS  Google Scholar 

  28. Das UN: Oxy radicals and their clinical implications. Curr Sci 1993, 65:964–968.

    CAS  Google Scholar 

  29. Kumar KV, Das UN: Lipid peroxides and essential fatty acids in patients with coronary heart disease. J Nutr Med 1994, 4:33–37.

    Google Scholar 

  30. Das UN, Kumar KV, Mohan IK: Lipid peroxides and essential fatty acids in patients with diabetes mellitus and diabetic nephropathy. J Nutr Med 1994, 4:149–155.

    Google Scholar 

  31. Kumar KV, Das UN: Are free radicals involved in the pathobiology of human essential hypertension? Free Rad Res Commun 1993, 19:59–66.

    CAS  Google Scholar 

  32. Das UN: Folic acid says NO to vascular diseases. Nutrition 2003, 19:686–692.

    Article  PubMed  CAS  Google Scholar 

  33. Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation 2003, 107:391–397.

    Article  PubMed  Google Scholar 

  34. Kern PA, Di Gregorio GB, Lu T, et al.: Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-a expression. Diabetes 2003, 52:1779–1785. In this study, and in Bruun et al. [35•], it was shown that adiponectin levels are decreased in obesity insulin resistance, and that TNF-α suppresses its production.

    Article  PubMed  CAS  Google Scholar 

  35. Bruun JM, Lihn AS, Verdich C, et al.: Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003, 285:E527-E533. In this study, and in Kern et al. [34•], it was shown that adiponectin levels are decreased in obesity insulin resistance, and that TNF-α suppresses its production.

    PubMed  CAS  Google Scholar 

  36. Matsubara M, Namioka K, Katayose S: Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur J Endocrinol 2003, 148:657–662.

    Article  PubMed  CAS  Google Scholar 

  37. Ouchi N, Kihara S, Funahashi T, et al.: Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003, 107:671–674.

    Article  PubMed  CAS  Google Scholar 

  38. Hattori Y, Matsumura M, Kasai K: Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res 2003, 58:186–195.

    Article  PubMed  CAS  Google Scholar 

  39. Devaraj S, Xu DY, Jialal I: C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells. Circulation 2003, 107:398–404.

    Article  PubMed  CAS  Google Scholar 

  40. Lindsay RS, Funahashi T, Hanson RL, et al.: Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360:57–58.

    Article  PubMed  CAS  Google Scholar 

  41. Spranger J, Kroke A, Mohlig M, et al.: Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003, 361:226–228.

    Article  PubMed  CAS  Google Scholar 

  42. Esposito K, Pontillo A, Di Palo C, et al.: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003, 289:1799–1804.

    Article  PubMed  CAS  Google Scholar 

  43. Sciacqua A, Candigliota M, Ceravolo R, et al.: Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Diabetes Care 2003, 26:1673–1678.

    Article  PubMed  Google Scholar 

  44. Yatagai T, Nishida Y, Nagasaka S, et al.: Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men. Endocr J 2003, 50:233–238.

    Article  PubMed  CAS  Google Scholar 

  45. Venugopal SK, Devaraj S, Yuhanna I, et al.: Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002, 106:1439–1441.

    Article  PubMed  CAS  Google Scholar 

  46. Fernandez-Real JM, Vayreda M, Richart C, et al.: Circulating interleukins 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001, 86:1154–1159.

    Article  PubMed  CAS  Google Scholar 

  47. Chae CU, Lee RT, Rifai N, Ridker PM: Blood pressure and inflammation in apparently healthy men. Hypertension 2001, 38:399–403.

    PubMed  CAS  Google Scholar 

  48. Abramson JL, Weintraub WS, Vaccarino V: Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 2002, 39:197–202.

    Article  PubMed  CAS  Google Scholar 

  49. Bermudez EA, Rifai N, Buring J, et al.: Interrelationships among circulating interleukins-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002, 22:1668–1673.

    Article  PubMed  CAS  Google Scholar 

  50. Seshiah PN, Weber DS, Rocic P, et al.: Angiotensin II stimulation of NAD(P)H oxidase activity. Circulation Res 2002, 91:406–413.

    Article  PubMed  CAS  Google Scholar 

  51. Furuhashi M, Ura N, Higashiura K, et al.: Blockade of the rennin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003, 42:76–81.

    Article  PubMed  CAS  Google Scholar 

  52. Das UN: Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-b to prevent human essential hypertension. Eur J Clin Nutr, In press.

  53. Diamond J: The double puzzle of diabetes. Nature 2003, 423:599–602.

    Article  PubMed  CAS  Google Scholar 

  54. Jovinge S, Hamsten A, Tomvall P, et al.: Evidence for a role of tumor necrosis factor alpha in disturbances of triglycerides and glucose metabolism predisposing to coronary heart disease. Metabolism 1998, 47:113–118.

    Article  PubMed  CAS  Google Scholar 

  55. Corica F, Allegra A, Corsonello A, et al.: Relationship between plasma leptin levels and the tumor necrosis factor alpha system in obese subjects. Int J Obes Metab Disord 1999, 23:355–360.

    Article  CAS  Google Scholar 

  56. Chu N-F, Spiegelman D, Rifai N, et al.: Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obes 2000, 24:1085–1092.

    Article  CAS  Google Scholar 

  57. Denicola A, Batthyany C, Lissi E, et al.: Diffusion of nitric oxide into low density lipoprotein. J Biol Chem 2002, 277:932–936.

    Article  PubMed  CAS  Google Scholar 

  58. Das UN: Nutritional factors in the pathobiology of human essential hypertension. Nutrition 2001, 17:337–346.

    Article  PubMed  CAS  Google Scholar 

  59. Tomilinson JW, Moore J, Cooper MS, et al.: Regulation of expression of 11b-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 2001, 142:1982–1989.

    Article  Google Scholar 

  60. Das UN: Is insulin an anti-inflammatory molecule? Nutrition 2001, 17:409–413. This is one of the first reports to suggest that insulin might have anti-inflammatory actions.

    Article  PubMed  CAS  Google Scholar 

  61. Das UN: A Perinatal Strategy for Preventing Adult Disease: The Role of Long-Chain Polyunsaturated Fatty Acids. Boston: Kluwer Academic Publishers; 2002.

    Google Scholar 

  62. Jeschke MG, Einspanier R, Klein D, et al.: Insulin attenuates the systemic inflammatory response. Mol Med 2002, 8:443–450. In this study, the authors showed that insulin augments IL-4 and IL-10 production and inhibits that of pro-inflammatory cytokines.

    PubMed  CAS  Google Scholar 

  63. Gao F, Gao E, Yue T-L, et al.: Nitric oxide mediates the anti-apoptotic effect of insulin in myocardial ischemiareperfusion. The roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002, 105:1497–1502.

    Article  PubMed  CAS  Google Scholar 

  64. Dandona P, Aljada A, Mohanty P: The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 2002, 45:924–930. In this review, the authors outlined evidences for the anti-inflammatory actions of insulin.

    Article  PubMed  CAS  Google Scholar 

  65. Whincup PH, Gilg JA, Papacosta O, et al.: Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ 2002, 324:1–6.

    Article  Google Scholar 

  66. Kalhan R, Puthawala K, Agarwal S, et al.: Altered lipid profile, leptin, insulin, and anthropometry in offspring of South Asian immigrants in the United States. Metabolism 2001, 50:1197–1202.

    Article  PubMed  CAS  Google Scholar 

  67. Das UN: Pathobiology of metabolic syndrome X in obese and non-obese South Asian Indians: further discussion and some suggestions. Nutrition 2003, 19:560–562.

    Article  PubMed  Google Scholar 

  68. Berenson GS, Srinivasan SR: Prevention of atherosclerosis in childhood. Lancet 1999, 354:1223–1224.

    Article  PubMed  CAS  Google Scholar 

  69. Barker DJP: Mothers, Babies and Health in Later Life, edn 2. Edinburgh: Churchill Livingstone; 1998.

    Google Scholar 

  70. Barker DJ, Hales CN, Fall CH, et al.: Type 2 (non-insulin dependent) diabetes mellitus, hypertension, and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993, 36:62–67.

    Article  PubMed  CAS  Google Scholar 

  71. Lucas A, Fewtrell MS, Cole TJ: Fetal origins of adult diseasethe hypothesis revisited. BMJ 1999, 319:245–249.

    PubMed  CAS  Google Scholar 

  72. Mokdad AH, Bowman BA, Ford ES, et al.: The continuing epidemics of obesity and diabetes in the United States. JAMA 2001, 286:1195–1200.

    Article  PubMed  CAS  Google Scholar 

  73. Krishnaswamy K, Prasad MPR: The changing epidemiologic scene: malnutrition versus chronic diseases in India. Nutrition 2001, 17:166–168.

    Article  PubMed  CAS  Google Scholar 

  74. Dandona P, Mohanty P, Ghanim H, et al.: The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carboxylation. J Clin Endocrinol Metab 2001, 86:355–362.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Reflexis Systems, Inc., 1420 Providence Highway, Suite #266, 02062, Norwood, MA, USA

    Undurti N. Das MD, FAMS

Authors
  1. Undurti N. Das MD, FAMS
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Das, U.N. Metabolic syndrome X: An inflammatory condition?. Current Science Inc 6, 66–73 (2004). https://doi.org/10.1007/s11906-004-0014-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-004-0014-8

Keywords

Search

Navigation